Enhanced Expression of the Multidrug Resistance Gene in Vindesine-Resistant Human Esophageal Cancer Cells | Citedby Results | Oncology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Enhanced Expression of the Multidrug Resistance Gene in Vindesine-Resistant Human Esophageal Cancer Cells

Oncology (1994) 51 (5): 440–445.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Association of the 1236C>T variant of the multidrug resistance 1 gene with esophageal squamous cell carcinoma development and prognosis

Niloofar Ghobadi
Ghazaleh Khalili-Tanha
Mehrane Mehramiz
Mina Maftooh
Nastaran Bani
Soodabeh ShahidSales
Majid Khazaei
Saeideh Ahmadi-Simab
Raheleh Rahbarian
Hassan Ramshini
Gordon A. Ferns
Masoumeh Gharib
Amir Avan

Human Gene (2023) 35: 201137.

Pharmacological Activity of Cepharanthine

Ke Liu
Bixia Hong
Shuqi Wang
Fuxing Lou
Yecheng You
Ruolan Hu
Amna Shafqat
Huahao Fan
Yigang Tong

Molecules (2023) 28 (13): 5019.

ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer

David Vrana
Viktor Hlavac
Veronika Brynychova
Radka Vaclavikova
Cestmir Neoral
Jiri Vrba
Rene Aujesky
Marcel Matzenauer
Bohuslav Melichar
Pavel Soucek

International Journal of Molecular Sciences (2018) 19 (3): 868.

Amplification of the ABCB1 region accompanied by a short sequence of 200bp from chromosome 2 in lung cancer cells

Kunio Kitada
Tomoaki Yamasaki
Satoko Aikawa

Cancer Genetics and Cytogenetics (2009) 194 (1): 4.

Vindesine in the Treatment of Leukaemia

Nicola Gökbuget
Dieter Hoelzer

Leukemia & Lymphoma (1997) 26 (5-6): 497.

The comparative clinical pharmacology of vincristine and vindesine: Does vindesine offer any advantage in clinical use?

Simon Joel

Cancer Treatment Reviews (1995) 21 (6): 513.